Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Biotech-bay    crawled time : 21:00    save search

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
Published: 2024-01-31 (Crawled : 21:00) - biospace.com/
PLSE | $6.77 -1.31% 39K twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 4.4% C: -2.42%

cardiac symposium presentation cellfx study
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.885 -1.12% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 0.0% C: 0.0%

disease global collaboration trial
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
Published: 2023-08-29 (Crawled : 21:00) - biospace.com/
MS | News 0 d | $93.9 0.15% 780K twitter stocktwits trandingview |
Finance
| | O: 0.64% H: 0.0% C: 0.0%
PSNL | $1.325 -3.99% 48K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 9.27% C: 7.95%

conference global
Outset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-08-29 (Crawled : 21:00) - biospace.com/
MS | News 0 d | $93.9 0.15% 780K twitter stocktwits trandingview |
Finance
| | O: 0.64% H: 0.0% C: 0.0%
OM | $2.57 4.47% 100K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 5.75% C: 5.04%

conference global medical
Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results
Published: 2023-08-15 (Crawled : 21:00) - biospace.com/
A | $138.74 -0.33% 140K twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.69% C: -0.52%

year financial results
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
Published: 2023-08-11 (Crawled : 21:00) - biospace.com/
CDNA | $8.14 -1.09% 42K twitter stocktwits trandingview |
Health Technology
| | O: -1.03% H: 4.07% C: -7.1%

molecular
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
Published: 2023-05-25 (Crawled : 21:00) - biospace.com/
BEAT | $2.01 -1.47% 3.5K twitter stocktwits trandingview |
Health Technology
| | O: 14.64% H: 6.49% C: -2.16%

patent cardiac granted system
Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results
Published: 2023-05-23 (Crawled : 21:00) - biospace.com/
A | $138.74 -0.33% 140K twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 1.17% C: -0.3%

year financial results
GRAIL to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting
Published: 2023-05-22 (Crawled : 21:00) - biospace.com/
ILMN | $122.54 -1.54% 84K twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 2.46% C: 1.67%

asco meeting
GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-04-19 (Crawled : 21:00) - biospace.com/
ILMN | $122.54 -1.54% 84K twitter stocktwits trandingview |
Health Technology
| | O: -1.0% H: 2.76% C: 2.48%

association solution positive cancer research meeting
Personalis to Announce First Quarter 2023 Financial Results
Published: 2023-04-19 (Crawled : 21:00) - biospace.com/
PSNL | $1.325 -3.99% 48K twitter stocktwits trandingview |
Health Technology
| | O: -1.5% H: 4.18% C: 0.76%

financial results
ALX Oncology and Quantum Leap Healthcare CollaborativeTM Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer
Published: 2023-03-14 (Crawled : 21:00) - biospace.com/
ALXO M | $15.565 0.42% 100K twitter stocktwits trandingview |
Commercial Services
| | O: 1.95% H: 2.09% C: -8.54%

quantum breast trial leap cancer
Agilent to Present at Barclays Global Healthcare Conference
Published: 2023-03-06 (Crawled : 21:00) - biospace.com/
A | $138.74 -0.33% 140K twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 1.45% C: -0.08%

global conference
Movano Inc. to Report Fourth Quarter 2022 Financial Results on Monday, March 20, 2023
Published: 2023-02-23 (Crawled : 21:00) - biospace.com/
MOVE | $0.4841 940 twitter stocktwits trandingview |
Manufacturing
| | O: -4.72% H: 3.31% C: 2.48%

report financial results
Pliant Therapeutics Receives Orphan Designation from the European Medicines Agency for Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2022-12-15 (Crawled : 21:00) - biospace.com/
PLRX | $12.33 -1.52% 28K twitter stocktwits trandingview |
Health Technology
| | O: -1.72% H: 3.29% C: 3.02%

pln-7480 treatment fibrosis designation therapeutics
IDEAYA Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-08 (Crawled : 21:00) - biospace.com/
IDYA | News | $40.2 3.02% 63K twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 7.17% C: 0.95%

financial update results
AMGEN ANNOUNCES WEBCAST OF 2022 CREDIT SUISSE GLOBAL HEALTHCARE CONFERENCE
Published: 2022-11-04 (Crawled : 21:00) - biospace.com/
AMGN | News | $273.905 0.13% 270K twitter stocktwits trandingview |
Health Technology
| | O: -1.48% H: 2.81% C: 2.71%

global conference
Mirum’s LIVMARLI Data Featured in Two Late-Breaker Presentations at The Liver Meeting of the American Association for the Study of Liver Diseases
Published: 2022-10-31 (Crawled : 21:00) - biospace.com/
MIRM | $24.14 -1.15% 24K twitter stocktwits trandingview |
Health Technology
| | O: -0.76% H: 0.82% C: -4.65%

liver meeting livmarli study
New Data Suggest Veracyte’s Envisia Genomic Classifier Can Help Predict Disease Progression in Interstitial Lung Disease Patients Treated with Combination Immunosuppressive Therapy
Published: 2022-09-07 (Crawled : 21:00) - biospace.com/
VCYT | News | $19.8 -0.15% 28K twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 4.52% C: 4.1%

lung disease genomic therapy
Atara Biotherapeutics to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
Published: 2022-08-01 (Crawled : 21:00) - biospace.com/
ATRA | $0.701 -2.45% 58K twitter stocktwits trandingview |
Health Technology
| | O: -0.66% H: 1.66% C: -5.32%

results
Gainers vs Losers
66% 34%

Top 10 Gainers
CZOO | $11.44 129.26% 4.6M twitter stocktwits trandingview |

AMST | $3.4 70.0% 51M twitter stocktwits trandingview |
Technology Services

BOF | $1.78 52.14% 15M twitter stocktwits trandingview |

CSSE 4 | $0.23 51.02% 46M twitter stocktwits trandingview |
Consumer Services

TROO | $1.57 44.04% 2.8M twitter stocktwits trandingview |
Manufacturing

RILY | $30.87 42.13% 7.8M twitter stocktwits trandingview |
Finance

LICN | $0.76 35.71% 6.2M twitter stocktwits trandingview |

MULN | News | $3.53 29.3% 4.8M twitter stocktwits trandingview |
Information

RBBN 4 | $3.26 26.85% 1.2M twitter stocktwits trandingview |
Electronic Technology

RCAT | $1.52 26.67% 1.3M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.